Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maia Scientific was a Belgian life sciences company that specialized in high-content screening (HCS) and automated cellular imaging technologies. The company is most notable for developing the Opera system, a high-speed confocal microplate imaging reader that became an industry standard for drug discovery and phenotypic screening. Their platform integrated advanced optics, high-speed robotics, and sophisticated image analysis software to allow researchers to visualize and quantify complex cellular processes. In 2005, Maia Scientific was acquired by PerkinElmer for approximately $14.2 million to bolster its cellular analysis portfolio. The technology developed by Maia Scientific continues to be a core part of the high-content analysis solutions offered by Revvity today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maia Scientific.